Can PET/CT substitute for bone scintigraphy in assessment of bone metastases in lung cancer patients?

被引：0
|
作者：
Watanabe, H. [1 ]
Monzawa, S. [1 ]
Adachi, S. [1 ]
Hamanaka, A. [1 ]
Kitamura, Y. [1 ]
Izaki, K. [1 ]
Okada, M. [1 ]
Satouchi, M. [1 ]
Negoro, S. [1 ]
Takada, Y. [1 ]
机构：
[1] Hyogo Med Ctr Adults, Akashi, Hyogo, Japan
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2006年 / 24卷 / 18期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
7203
引用
收藏
页码：414S / 414S
页数：1
相关论文
共 50 条
  • [41] Assessment of Bone Metastases in Patients with Prostate Cancer-A Comparison between 99mTc-Bone-Scintigraphy and [68Ga]Ga-PSMA PET/CT
    Thomas, Lena
    Balmus, Caroline
    Ahmadzadehfar, Hojjat
    Essler, Markus
    Strunk, Holger
    Bundschuh, Ralph A.
    PHARMACEUTICALS, 2017, 10 (03)
  • [42] Detection of bone metastases in patients with lung cancer: 99mTc-MDP planar bone scintigraphy, 18F-Fluoride PET or 18F-FDG PET-CT
    Krueger, Stefan
    Glatting, Gerhard
    Pauls, Sandra
    Reske, Sven
    Buck, Andreas K.
    JOURNAL OF THORACIC ONCOLOGY, 2009, 4 (09) : S376 - S376
  • [43] Gastric cancer bone metastases together with osteopoildlosis diagnosed using bone scintigraphy and 18F-FDG PET/CT
    Prado Wohlwend, S.
    Sanchez Vano, R.
    Sopena Novales, P.
    Uruburu Garcia, E.
    Aparisi Rodriguez, F.
    Martinez Carsi, C.
    REVISTA ESPANOLA DE MEDICINA NUCLEAR E IMAGEN MOLECULAR, 2017, 36 (03): : 189 - 193
  • [44] Comparison of bone scintigraphy and 18F-FDG PET-CT in a prostate cancer patient with osteolytic bone metastases
    Kara, P. Ozcan
    Kara, T.
    Gedik, G. Kara
    Sari, O.
    Sahin, O.
    REVISTA ESPANOLA DE MEDICINA NUCLEAR, 2011, 30 (02): : 94 - 96
  • [45] Comparison of PSMA-PET/CT, choline-PET/CT, NaF-PET/CT, MRI, and bone scintigraphy in the diagnosis of bone metastases in patients with prostate cancer: a systematic review and meta-analysis
    Zhou, Jing
    Gou, Zhengxing
    Wu, Renhui
    Yuan, Yuan
    Yu, Guiquan
    Zhao, Yigang
    SKELETAL RADIOLOGY, 2019, 48 (12) : 1915 - 1924
  • [46] Comparison of PSMA-PET/CT, choline-PET/CT, NaF-PET/CT, MRI, and bone scintigraphy in the diagnosis of bone metastases in patients with prostate cancer: a systematic review and meta-analysis
    Jing Zhou
    Zhengxing Gou
    Renhui Wu
    Yuan Yuan
    Guiquan Yu
    Yigang Zhao
    Skeletal Radiology, 2019, 48 : 1915 - 1924
  • [47] Comparison of 18FDG PET-CT and bone scintigraphy for detection of bone metastases in breast cancer patients. A meta-analysis
    Rong, Jian
    Wang, Siyang
    Ding, Qiue
    Yun, Miao
    Zheng, Zhousan
    Ye, Sheng
    SURGICAL ONCOLOGY-OXFORD, 2013, 22 (02): : 86 - 91
  • [48] 18F-Fluoride PET/CT is highly effective for excluding bone metastases even in patients with equivocal bone scintigraphy
    Bortot, Daniel C.
    Amorim, Barbara J.
    Oki, Glaucia C.
    Gapski, Sergio B.
    Santos, Allan O.
    Lima, Mariana C. L.
    Etchebehere, Elba C. S. C.
    Barboza, Marycel F.
    Mengatti, Jair
    Ramos, Celso Dario
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2012, 39 (11) : 1730 - 1736
  • [49] 18F-Fluoride PET/CT is highly effective for excluding bone metastases even in patients with equivocal bone scintigraphy
    Daniel C. Bortot
    Bárbara J. Amorim
    Glaucia C. Oki
    Sérgio B. Gapski
    Allan O. Santos
    Mariana C. L. Lima
    Elba C. S. C. Etchebehere
    Marycel F. Barboza
    Jair Mengatti
    Celso Dario Ramos
    European Journal of Nuclear Medicine and Molecular Imaging, 2012, 39 : 1730 - 1736
  • [50] PET/CT for monitoring therapy response in breast cancer patients with bone metastases
    Beheshti, Mohsen
    Langsteger, Werner
    RADIOLOGY, 2008, 249 (01) : 389 - 390
12345